FDA Drug Discontinuation

$79 / year

The Food and Drug Administration (FDA) Drug discontinuation database includes information about current drugs in discontinuations of specific drug products, resource information, and relevant links.

Complexity

The Food and Drug Administration (FDA) Drug discontinuation database includes information about current drugs in discontinuations of specific drug products including posting date, updated date, therapeutic category, resource information and relevant links.

Date Created

2014-01

Last Modified

2017-07-27

Version

2017-07-27

Update Frequency

Irregular

Temporal Coverage

N/A

Spatial Coverage

United States

Source

John Snow Labs => U.S. Food and Drug Administration (FDA)

Source License URL

John Snow Labs Standard License

Source License Requirements

N/A

Source Citation

N/A

Keywords

FDA Drug Discontinuation, Drug Discontinuation, FDA Drug Database, FDA Drugs, Current Drug Discontinuations, Drug Discontinuation

Other Titles

Discontinuations Reported to FDA, Discontinuations Listed by Generic Name or Active Ingredient

NameDescriptionTypeConstraints
Generic_Name_or_Active_IngredientProduct Namestringrequired : 1
Therapeutic_CategoriesTherapeutic Categories to productsstring-
LaboratoryLaboratory (MA Holder)stringrequired : 1
Last_UpdateLast status update datedate-
Company_Contact_InformationCompany Contact Informationstring-
PresentationPresentation of products including NDCstring-
Date_First_PostedPosting Datedate-
Related_InformationRelated Information about shortagestring-
Generic_Name_or_Active_IngredientTherapeutic_CategoriesLaboratoryLast_UpdateCompany_Contact_InformationPresentationDate_First_PostedRelated_Information
Calcitriol 1 mcg/mL InjectionRenalFresenius Kabi USA, LLC2014-01-31888-386-13001 mcg/mL; 1mL2014-01-31
Levobunolol HydrochlorideOphthalmologyPacific Pharma, Inc.2014-03-14800-811-41840.25% Solution2014-03-14
Rivastigmine tartrate (Exelon)NeurologyNovartis2014-01-29888-669-66822 mg/mL ; 120 mL Oral Solution2014-01-29
Reserpine TabletsCardiovascular; PediatricSandoz2016-08-30800-525-87470.1 mg 100s (NDC 0185-0032-01)Permanent discontinuation
Reserpine TabletsCardiovascular; PediatricSandoz2016-08-30800-525-87470.25 mg 100s (NDC 0185-0134-01)Permanent discontinuation
Reserpine TabletsCardiovascular; PediatricSandoz2016-08-30800-525-87470.1 mg 1000s (NDC 0185-0032-10)Permanent discontinuation
Reserpine TabletsCardiovascular; PediatricSandoz2016-08-30800-525-87470.25 mg 1000s (NDC 0185-0134-10)Permanent discontinuation
Denileukin Diftitox (Ontak) InjectionOncologyEisai2014-01-31888-422-4743150 mcg/mL, Eisai 2 mL vial (NDC 62856-0603-01)2014-01-31
Acarbose TabletsMylan Pharmaceuticals Inc.2015-12-14800-796-9526Acarbose Tablets 50 mg (NDC # 0378-2821-77)2015-12-14Market conditions
Acarbose TabletsMylan Pharmaceuticals Inc.2015-12-14800-796-9526Acarbose Tablets 25 mg (NDC # 0378-2820-77)2015-12-14Market conditions